These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20460872)

  • 1. Formulation development of stronger and quick disintegrating tablets: a crucial effect of chitin.
    Goel H; Kaur G; Tiwary AK; Rana V
    Yakugaku Zasshi; 2010 May; 130(5):729-35. PubMed ID: 20460872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
    Goel H; Tiwary AK; Rana V
    Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
    Goel H; Arora A; Tiwary AK; Rana V
    Pharm Dev Technol; 2011 Feb; 16(1):57-64. PubMed ID: 20028210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting.
    Goel H; Vora N; Rana V
    AAPS PharmSciTech; 2008; 9(3):774-81. PubMed ID: 18584333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and optimization of mouth/orally dissolving tablets using a combination of glycine, carboxymethyl cellulose and sodium alginate: a comparison with superdisintegrants.
    Vora N; Rana V
    Pharm Dev Technol; 2008; 13(3):233-43. PubMed ID: 18484492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant.
    Goel H; Vora N; Tiwary AK; Rana V
    Yakugaku Zasshi; 2009 May; 129(5):513-21. PubMed ID: 19420882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
    Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
    Moutasim MY; ElMeshad AN; El-Nabarawi MA
    Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and
    Sutthapitaksakul L; Thanawuth K; Huanbutta K; Sriamornsak P
    Pharmazie; 2022 Oct; 77(10):287-290. PubMed ID: 36273260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, Optimization and
    Ejeta F; Gabriel T; Joseph NM; Belete A
    Curr Drug Deliv; 2022; 19(1):129-141. PubMed ID: 34126894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone.
    Shu T; Suzuki H; Hironaka K; Ito K
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):193-8. PubMed ID: 11848208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
    Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
    Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approach of aceclofenac fast dissolving tablet.
    Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
    Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.